Tuesday, November 19, 2019 4:50:11 PM
SUCH A DEAL.
On August 18, 2017, the Company acquired all of the assets and capital stock of GeoTraq by way of merger, the result of which GeoTraq became a wholly-owned subsidiary of the Company.
The final fair value of the single identifiable intangible asset acquired in the GeoTraq acquisition is a U.S. patent USPTO reference No. 10,182,402 titled “Locator Device with Low Power Consumption” together with the assignment of intellectual property that included historical know-how, designs and related manufacturing procedures was $26,097 which included the deferred income tax liability associated with the intangible asset. Total consideration paid in connection with the acquisition of GeoTraq consisted of $200 in cash, unsecured promissory notes bearing interest at the annual rate of 1.29% maturing on August 18, 2018 in the aggregate principal of $800, and 288,588 shares (exact number) of Series A-1 Preferred Stock (as defined below) with a final fair value of $14,963. See Note 17 – Series A-1 Preferred Stock. In connection with the acquisition, an additional intangible asset amount was recorded in the amount of $10,134 and an offsetting deferred tax liability recorded of the same amount, $10,134, to reflect the future tax liability attributable to the GeoTraq asset acquired. There were no other assets acquired or liabilities assumed.
At the time of the acquisition of GeoTraq, GeoTraq had no business operations, one intangible asset and historical know-how and designs. GeoTraq is in the development stage.
GOOD GRIEF
Recent JAN News
- JanOne Regains Compliance with Nasdaq's Listing Requirements • PR Newswire (US) • 03/15/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:22:34 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/09/2024 05:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:28:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:33:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/22/2023 09:00:42 PM
- JanOne to Present at the Dawson James 8th Annual Investment Conference • PR Newswire (US) • 09/21/2023 03:30:00 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:33:01 PM
- JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference • PR Newswire (US) • 08/31/2023 05:30:00 PM
- JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain • PR Newswire (US) • 08/29/2023 05:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/28/2023 09:20:13 PM
- JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/25/2023 06:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 08/24/2023 08:30:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 08:33:11 PM
- JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/22/2023 09:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/22/2023 04:54:17 PM
- JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules • PR Newswire (US) • 08/18/2023 11:00:00 PM
- JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting • PR Newswire (US) • 08/18/2023 04:42:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/16/2023 07:55:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 08:39:17 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/07/2023 08:19:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 08:24:10 PM
- JanOne files international patent application for methods of using low dose naltrexone to treat chronic pain • PR Newswire (US) • 06/28/2023 12:30:00 PM
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM